-
NOMIS & Science Young Explorer Award
The award is presented for outstanding research performed by the applicant as described in a 1,000-word essay. The application period for the 2021 award closes on 15 May 2021.
Visit
-
Planning Grants for Engineering Research Centers (ERC): due Feb 16, 2021
In response to a 2017 study from the National Academies of Sciences, Engineering, and Medicine (NASEM), the Engineering Research Centers (ERC) program piloted a planning grant opportunity in 2018. This solicitation is a continuation of this pilot program.
Visit
-
Coulter Translational Research Partnership Program: due Feb 21, 2021
The Coulter Program collaboratively works with UM faculty to develop medical device concepts invented at UM and license the related IP rights to medical device companies who complete development and seek FDA approvals. The Coulter Program now requires an LOI prior to receiving an invitation to submit a project proposal. The Coulter Program has two award programs – Enlighten and Evolve. Enlighten Award: Awardees receive direct mentoring from medical device industry experts and outside investors, market, regulatory and IP landscape assessments, and introductions to medical device companies. Program deliverables culminate with product strategic plans. Enlighten awardees will be invited to pitch for Evolve Awards to execute on strategic plans. Evolve Award: Uncover – New product design planning, early prototyping and verification studies. Emerge –Advanced prototype development, FDA interactions, validation studies (bench, animal, human), and partnering meetings with medical device companies.
Visit
-
SPARC-MDD Partnership: due Mar 1, 2021
The SPARC-MDD Partnership Grant provides funding and collaborative support for therapeutics projects led by U-M faculty. Selected projects have the potential to receive the equivalent of up to $1.5 million over a three-year period, including in-kind support in areas such as medicinal chemistry and preclinical development.
Visit
-
Small Business Transition Grant for Early Career Scientists: due Mar 10, 2021
This Funding Opportunity Announcement (FOA) aims to support early career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses.
Visit
-
KidneyX Artificial Kidney Prize: due Mar 24, 2021
A competition to accelerate artificial kidney development toward human clinical trials. Phase 1 of the Artificial Kidney Prize seeks solutions that enable and advance the functionality, effectiveness, and/or reliability of artificial kidneys.
Visit
-
MTRAC Innovation Hub for AgBio Starter Grant: due March 12, 2021
The Michigan Translational Research and Commercialization (MTRAC) Innovation Hub for Ag & Bio is the first in a series of specialized statewide commercialization programs with in-depth domain expertise in specific areas of research. Translational research funding to accelerate the commercialization of high potential Ag & Bio technology is available to innovators at institutions of higher education, non-profit research centers, and hospital systems throughout Michigan.
Visit
-
Richard G. Hankett Memorial Research Grant: due Apr 1, 2021
The Grant supports university-level multidisciplinary scientific studies on viral and bacterial infection-induced cancers. We welcome graduate student and post doctoral scientists from chemistry, pharmacology, biochemistry, engineering, biology, and any related disciplines to apply.
Visit
-
Centers of Research Translation (CORT) (P50 Clinical Trial Not Allowed): LOI due Apr 11, 2021
This Funding Opportunity Announcement (FOA) invites applications for Centers of Research Translation (CORT). Overall, a CORT research program should be carried out by a synergistic team of scientists who, through an interdisciplinary team science approach, will address a highly significant translational research challenge in a single or a group of highly-related disease(s) or condition(s) within the mission of the NIAMS.
Visit
-
NCI SBIR Concept Award: due July 23, 2021
NCI SBIR encourages small businesses developing highly innovative and transformative technologies that have the potential to create new scientific paradigms, establish entirely new and improved approaches to significantly improve cancer research, prevention, detection and care in pediatric and/or rare cancers to apply for the NCI SBIR Innovative Concept Award.
Visit
-
University of Michigan and Peking University Health Science Center
Following a temporary suspension of the request for proposals (RFP) process because of the COVID-19 pandemic, the Joint Institute is pleased to announce the reactivation of the 2020 awards cycle with an emphasis on COVID-related projects. The JI accepts proposals on an annual basis from investigators in any health science discipline working collaboratively across the University of Michigan and Peking University Health Science Center.
Visit
-
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
The NIH Office of Science Policy (OSP) within the Office of the Director (OD) announces the availability of administrative supplements to support 1) research on bioethical issues to develop or support the development of an evidence base that may inform future policy directions, and/or 2) certain efforts to develop or augment bioethics research capacity. Applicants may propose to supplement parent awards focused on bioethics or to add a component related to bioethics to a parent award in which bioethics was not the focus. Note that applications must be within the general scope of the parent award.
Visit
-
Tissue Engineering and Regeneration Grant (training grant)
Tissue Engineering and Regeneration (TEAM) is an interdisciplinary research-intensive training program for individuals who wish to pursue careers in the oral sciences with a focus in the area of restoration of oral-craniofacial tissues.
Visit
-
Regenerative Medicine Innovation Project (RMIP)
The Regenerative Medicine Innovation Project (RMIP) was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA).
Visit
-
Rapid Acceleration of Diagnostics (RadX)
The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADxSM) initiative to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. Accurate, fast, easy-to-use, and widely accessible testing is required before the nation can safely return to normal life.
Visit
-
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease.
Visit
-
Enabling Technologies to Accelerate Development of Oral Biodevices
This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices.
Visit
-
MTRAC for Life Sciences: Kickstart Early-Stage Funding
The Kickstart Awards offer funding up to $42,500, with all awarded projects requiring a cost share from the investigator/institution. Proposals are reviewed and awarded semi-annually, with due dates on February 1 and August 1. All interested researchers must complete a pre-submission application before submitting a full proposal.
Visit